Pharmaceutical firm Pfizer and France’s national agricultural research agency, INRA, have signed an agreement to work more closely on animal and public health.
The agreement is aimed at making it easier for the public agency and the private firm to collaborate in areas such as vaccine development, infectious disease treatments and animal genetics, and for them to produce joint patents.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.